To investigate whether the signaling pathway is involved in MSSV-mediated anti-proliferative effect of bladder cancer cells, we assessed the phosphorylation level of MAPKs (ERK1/2, p38MAPK, and JNK) and AKT in MSSV-treated cells. The gene discussed is MAPK3; the disease is urinary bladder carcinoma.